Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Start Date
3/26/2025
Completion Date
7/1/2034
Summary
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Detailed Description
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Intracept™ Intraosseous Nerve Ablation
Conditions
Locations
Flagstaff Bone & Joint
Flagstaff, Arizona 86001
United States
Innovative Pain and Wellness
Phoenix, Arizona 85014
United States
MarinHealth Spine Institute
Larkspur, California 94939
United States
The Spine Wellness Center in Westport
Westport, Connecticut 06880
United States
Washington Hospital Center
Washington D.C., District of Columbia 20010
United States
Orlando Regional Medical Center
Orlando, Florida 32806
United States
North Idaho Day Surgery, LLC
Post Falls, Idaho 83854
United States
Illinois Bone and Joint Institute
Barrington, Illinois 60010
United States
Commonwealth Pain and Spine
Lexington, Kentucky 40509
United States
Ochsner Clinic Foundation
New Orleans, Louisiana 70115
United States
iSpine Clinics
Maple Grove, Minnesota 55369
United States
New York Spine and Pain Specialists
Port Jefferson Station, New York 11776
United States
University of Rochester
Rochester, New York 14618
United States
Novant Health Spine Specialists
Bermuda Run, North Carolina 27106
United States
Pacific Sports and Spine
Eugene, Oregon 97404
United States
Allegheny General Hospital
Pittsburgh, Pennsylvania 15212
United States
Cy-Pain and Spine
Houston, Texas 77065
United States
University of Utah Orthopaedic Center
Salt Lake City, Utah 84108
United States